Capital Research Files Schedule 13G Showing No Stake in LEVI
Rhea-AI Filing Summary
Capital Research Global Investors filed a Schedule 13G reporting its position in Levi Strauss & Co. common stock as a beneficial owner of 0 shares, representing 0.0% of the 104,585,522 shares the filing states are outstanding. The filing identifies CRGI as an investment adviser division of Capital Research and Management Company and related investment management entities and states that, collectively under the name Capital Research Global Investors, they are deemed to beneficially own 0 shares.
The filing shows 0 sole and 0 shared voting powers and 0 sole and 0 shared dispositive powers, and includes a certification that the securities (if any) are held in the ordinary course of business and not to influence control of the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Institutional filer reports no ownership; no immediate market impact.
The Schedule 13G indicates Capital Research Global Investors holds 0 shares (0.0%) of Levi Strauss, with all voting and dispositive powers reported as 0. From an investor-analysis perspective, this filing is neutral: it neither signals accumulation nor divestiture by this large investment-advisory group. The disclosure confirms the adviser is filing under the investment-adviser classification and includes the ordinary-course certification, which further reduces the likelihood of activist intent. Impact assessment: not impactful for valuation or control.
TL;DR: Governance implications minimal; filer asserts no control interest.
The report shows no voting or dispositive rights attributed to CRGI, and the certification states holdings are not intended to influence control. For governance monitoring, this filing provides a clear record that the named investment management entities do not hold a stake that could affect board composition or corporate control. As such, this disclosure is procedural and carries no material governance risk or signal of shareholder activism.